Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Report Description
Suicidal thoughts can be aroused due to various underlying factors such as financial burden, social issues or drug side effects. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. Anti-depressants and anti-psychotics are the most widely used medications for treating suicidal tendencies. According to the World Health Organization (WHO), over 800,000 people die due to suicide annually. Development of an effective anti-suicidal drug could be a major breakthrough in reducing the death toll. Currently, non-profit organizations such as Stop Suicide, Stop Youth Suicide, and American Foundation for Suicide Prevention are providing moral and social support to people with reported suicidal thoughts. This however, is ineffective until the organization is alerted of the person at risk for suicide.
Market Dynamics
Off-label use of these drugs for suicidal ideation has been a practice for years, as there are no approved anti-suicide specific drug yet. However, the dynamics is expected to change in the following few years with the launch of first oral therapeutic drug for acute suicidal ideation. This would disrupt the use of antidepressants and anti-psychotic drugs for the treatment of suicidal tendencies. Suicidal incidences are high in low and middle income countries according to the WHO 2016 statistics. Although the incidence in Asia, East Africa, and Eastern European region is high, these regions lag in terms of availability of affordable medications and healthcare facilities. Therefore developed economies of North America and Western Europe are key target regions for manufacturers in the near future. Rampant economic growth and projected strengthening of the healthcare infrastructure in emerging economies in towards the first half of the following decade is projected to shift the focus of these companies towards highly populous regions of India and China in the long run.
Market Taxonomy
This report segments the global anti-suicide drugs market on the basis of chemistry type, and geography. On the basis of chemistry type, the market is categorized into anti-depressants and anti-anxiety drugs, anti-psychotic drugs, NMDA antagonist and antibiotic analogs. For comprehensive understanding of market dynamics, the global anti-suicide devices market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.
Key features of the study:
• This report provides in-depth analysis of the anti-suicide drugs and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 - 2024, considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global anti-suicide drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson
• Insights from this report would allow marketers and the management of companies to make informed decision with respect to their future product launch, competitive scenario, geographic expansion, and marketing tactics
• The global anti-suicide devices market report caters to various stakeholders in this industry, including investors, drug manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the anti-suicide drugs market would provide stakeholders vital inputs to make strategic decisions accordingly
Detailed Segmentation:
• Global Anti-Suicide Drugs Market, By Chemistry Type:
o Anti-Depressants and Anti-Anxiety Drugs
o Anti-Psychotic Drugs
o NMDA Antagonist
o Antibiotic Analog
• Global Anti-Suicide Drugs Market, By Geography:
o North America
U.S.
U.S. Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Canada
Canada Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
o Europe
U.K.
U.K Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Germany
Germany Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Italy
Italy Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
France
France Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Spain
Spain Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Russia
Russia Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Rest of Europe
Rest of Europe Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
o Asia-Pacific
China
China Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
India
India Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Japan
Japan Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
ASEAN
ASEAN Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Australia
Australia Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
South Korea
South Korea Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Rest of Asia Pacific (APAC)
Rest of Asia Pacific (APAC) Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
o Latin America
Brazil
Brazil Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Mexico
Mexico Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Argentina
Argentina Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Rest of Latin America
Rest of Latin America Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
o Middle East
GCC
GCC Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Israel
Israel Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Rest of Middle East
Rest of Middle East Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
o Africa
North Africa
North Africa Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
Central Africa
Central Africa Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
South Africa
South Africa Anti-Suicide Drugs Market, By Chemistry Type:
Anti-Depressant and Anti-Anxiety Drugs
Anti-Psychotic Drugs
NMDA Antagonist
Antibiotic Analog
• Company Profiles
o Pfizer, Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
o AstraZeneca plc
o Eli Lilly and Company
o Allergan plc
o GlaxoSmithKline plc
o Merck & Co., Inc.
o H. Lundbeck A/S
o NeuroRx, Inc.
o Johnson & Johnson
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet By Chemistry type
? Market Snippet By Geography
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Epidemiology
o Healthcare Spending
o PEST Analysis
o Pipeline Analysis
o Anti-Suicide Prevention Campaigns and Programs
4. Global Anti-Suicide Drugs Market, By Chemistry Type, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, 2014 - 2024
? Segment Trends
o Anti-Depressant and Anti-Anxiety Drugs
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Anti-Psychotic Drugs
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o NMDA Antagonist
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
o Antibiotic Analog
? Introduction
? Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (US$ Million)
5. Global Anti-Suicide Drugs Market, By Geography, 2014 - 2024 (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, For Regions, 2014 - 2024
o North America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.S.
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Canada
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
o Europe
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? U.K.
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Germany
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Italy
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? France
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Spain
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Russia
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Rest of Europe
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
o Asia Pacific
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? China
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? India
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Japan
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? ASEAN
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Australia
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? South Korea
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Rest of Asia Pacific
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
o Latin America
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Brazil
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Mexico
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Argentina
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Rest of Latin America
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
o Middle East
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? GCC Countries
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Israel
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Rest of Middle East
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
o Africa
? Market Share Analysis, By Country, 2015 and 2024 (%)
? Y-O-Y Growth Analysis, By Country, 2014 - 2024
? Northern Africa
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? Central Africa
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
? South Africa
? Country Trends
? Market Size and Forecast, By Chemistry Type, 2014 - 2024 (US$ Million)
6. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Pfizer, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? AstraZeneca plc
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? Eli Lilly and Company
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? Allergan plc
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? GlaxoSmithkline plc
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? Merck & Co., Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? H. Lundbeck A/S
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? NeuroRx, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
? Johnson & Johnson
? Company Overview
? Product Portfolio
? Financial Performance
? Key Developments
? Market Presence
7. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 40 market data tables and 44 figures on "Anti-Suicide Drugs Market - Global forecast to 2024".